IL-6 in Ovarian Cancer and Its Effects on Immunity
Author Information
Author(s): Kryczek I, Gryboś M, Karabon L, Klimczak A, Lange A
Primary Institution: Institute of Immunology and Experimental Therapy, Polish Academy of Sciences
Hypothesis
The study investigates the relationship between IL-6 production in ovarian carcinoma and the tumor's histiotype and biological characteristics, as well as its influence on local immunity.
Conclusion
IL-6 production in ovarian carcinoma is influenced by the tumor type and affects local immune cell composition.
Supporting Evidence
- IL-6 levels were higher in ovarian carcinoma patients compared to those with gastrointestinal cancer.
- IL-6 activity was higher in serous/mucinous ovarian carcinoma than in endometrioid and undifferentiated types.
- There was a correlation between IL-6 levels in peritoneal fluid and serum C-reactive protein levels.
- The immune cell profile in peritoneal fluid differed from that in blood.
- Higher proportions of Ki-67+ cells were found in undifferentiated tumors.
Takeaway
This study found that a substance called IL-6 in ovarian cancer can change how the immune system works, depending on the type of tumor.
Methodology
The study measured IL-6 levels in peritoneal carcinomatous fluid and analyzed immune cell composition in ovarian carcinoma patients.
Participant Demographics
Patients with advanced ovarian carcinoma.
Statistical Information
P-Value
0.0000
Statistical Significance
p=0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website